CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase SyndromeAnn‐Christin Pecher, Claudia Lengerke, Wolfgang Bethge et al.|JAMA|2023Cited by 234
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposiumOtávio Cabral-Marques, Gabriela Riemekasten, Guido Moll et al.|Autoimmunity Reviews|2023Cited by 46
Inhibition of effector B cells by ibrutinib in systemic sclerosisJakob Einhaus, Dominik Schneidawind, Ann‐Christin Pecher et al.|Arthritis Research & Therapy|2020Cited by 42
Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISALukas Bankamp, Reinhild Klein, Beate Preuß et al.|Frontiers in Immunology|2021Cited by 12
Invariant natural killer T cells are functionally impaired in patients with systemic sclerosisAnn‐Christin Pecher, Dominik Schneidawind, Felix Kettemann et al.|Arthritis Research & Therapy|2019Cited by 12